Clinical Trials Directory

Trials / Completed

CompletedNCT03612960

Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The overall goal of this study is to determine if switching to very low nicotine content cigarettes changes the function of brain circuitry involved in incentive salience and executive control among dependent smokers.

Detailed description

In a double-blind, randomized controlled trial, dependent smokers will be randomized to a 6-week very low nicotine content (VLNC) cigarette condition (N=50) or a 6-week normal nicotine content cigarette control condition (NNC; N=25). Participants will undergo functional magnetic resonance imaging (fMRI) scans at baseline and 6-weeks to investigate the nicotine-related modulation of brain circuitry involved in incentive salience valuation and executive control. Imaging tasks will engage the incentive salience of smoking cues and non-smoking rewards and executive control functions to identify changes in functional activity within, and effective connectivity between, known salience and executive control brain circuitry. A novel fMRI task using specialized odor presentation equipment and fMRI sequences will assess neural cue reactivity to smoke odors.

Conditions

Interventions

TypeNameDescription
DRUGVery low nicotine content cigarettesVery low nicotine content cigarettes
DRUGNormal nicotine content cigarettesNormal nicotine content cigarettes

Timeline

Start date
2020-02-20
Primary completion
2023-06-23
Completion
2023-06-23
First posted
2018-08-02
Last updated
2024-08-20
Results posted
2024-08-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03612960. Inclusion in this directory is not an endorsement.